Search

Each record is a registered study, a systematic-review registration or a publication. A registered or ongoing study is not a finding, and animal or cell research does not show an effect in people. The same study can appear under more than one subject, so the number of records is not a count of independent studies. You can also search an exact DOI, PubMed ID, NCT or CRD number. How to read these records.

58 study records (showing up to 30 per record type)

• Registered trial NCT05882084 Not completed: Recruiting
  Oral Supplementation of Astaxanthin on Skin Photoaging, Hydration and Elasticity
  Condition or outcome area: Photoaging
  2023-07-24 · Subject: Astaxanthin; 3,3'-dihydroxy-4,4'-diketo-beta,beta-carotene · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT05376501 Completed (results not assessed here)
  A Study to Evaluate the Effect of Astaxanthin in Healthy Participants
  Condition or outcome area: Healthy
  2022-06-08 · Subject: Astaxanthin; 3,3'-dihydroxy-4,4'-diketo-beta,beta-carotene · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT05437601 Phase 2 Completed (results not assessed here)
  Effect of Astaxanthin in Moderate to Severe Knee Osteoarthritis
  Condition or outcome area: Osteoarthritis, Knee
  2022-07-31 · Subject: Astaxanthin; 3,3'-dihydroxy-4,4'-diketo-beta,beta-carotene · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT05409092 Completed (results not assessed here)
  Astaxanthin, Exercise Inflammation, Skin Health
  Condition or outcome area: Inflammatory Response|Metabolic Disturbance|Immune Suppression
  2022-01-19 · Subject: Astaxanthin; 3,3'-dihydroxy-4,4'-diketo-beta,beta-carotene · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT03945526 Phase 1 Completed (results not assessed here)
  Effect of Astaxanthin Supplementation on Plasma Malondialdehyde Levels and NIHSS of Stroke Patients
  Condition or outcome area: Cerebral Stroke|Malondialdehyde|Oxidative Stress
  2010-03-23 · Subject: Astaxanthin; 3,3'-dihydroxy-4,4'-diketo-beta,beta-carotene · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT03807050 Completed (results not assessed here)
  Safety and Pharmacokinetics of Phaffia Rhodozyma Astaxanthin
  Condition or outcome area: Absorption; Chemicals
  2018-11-19 · Subject: Astaxanthin; 3,3'-dihydroxy-4,4'-diketo-beta,beta-carotene · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT03368872 Completed (results not assessed here)
  Clinical Trial of Astaxanthin Formulation With Exercise in Sarcopenia Elderly
  Condition or outcome area: Sarcopenia
  2015-10 · Subject: Astaxanthin; 3,3'-dihydroxy-4,4'-diketo-beta,beta-carotene · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT03310359 Completed (results not assessed here)
  Clinical Trial of Anti-oxidant Astaxanthin in Insulin-resistant Subjects
  Condition or outcome area: Metabolic Syndrome X
  2016-07 · Subject: Astaxanthin; 3,3'-dihydroxy-4,4'-diketo-beta,beta-carotene · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT02373111 Completed (results not assessed here)
  Effects of Isoflavone Combined With Astaxanthin on Skin Aging
  Condition or outcome area: Ageing|Photo-aging
  2015-03 · Subject: Astaxanthin; 3,3'-dihydroxy-4,4'-diketo-beta,beta-carotene · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT02310087 Completed (results not assessed here)
  Oral Astaxanthin and Semen Quality, Fertilization and Embryo Development in Assisted Reproduction Techniques Procedures
  Condition or outcome area: Infertility, Male
  2014-11 · Subject: Astaxanthin; 3,3'-dihydroxy-4,4'-diketo-beta,beta-carotene · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT05282355 Completed (results not assessed here)
  Astaxanthin Reduces Exercising Heart Rate.
  Condition or outcome area: Metabolic Flexibility
  2021-05-12 · Subject: Astaxanthin; 3,3'-dihydroxy-4,4'-diketo-beta,beta-carotene · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT05015374 Completed (results not assessed here)
  Effect of Astaxanthin on the Patients With Alzheimer Disease
  Condition or outcome area: To Evaluate the Possible Benefit of Astaxanthin on Alzheimer Disease
  2018-11-14 · Subject: Astaxanthin; 3,3'-dihydroxy-4,4'-diketo-beta,beta-carotene · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT04689984 Phase 2 / Phase 3 Not completed: Unknown
  The Benefits of Astaxanthin as Add on Therapy in the Management of Painful Diabetic Neuropathy Patient
  Condition or outcome area: Painful Diabetic Neuropathy
  2020-11-03 · Subject: Astaxanthin; 3,3'-dihydroxy-4,4'-diketo-beta,beta-carotene · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT03991286 Completed (results not assessed here)
  The Effect of Astaxanthin on Oxidative Stress Indices in Patients With Polycystic Ovary Syndrome
  Condition or outcome area: PCOS
  2020-01-20 · Subject: Astaxanthin; 3,3'-dihydroxy-4,4'-diketo-beta,beta-carotene · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT03664466 Not completed: Withdrawn
  Astaxanthin Effects on Osteoarthritis Associated Pain and Inflammatory Indicators
  Condition or outcome area: Osteoarthritis, Knee
  2021-04-29 · Subject: Astaxanthin; 3,3'-dihydroxy-4,4'-diketo-beta,beta-carotene · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT03460860 Completed (results not assessed here)
  Astaxanthin (2 mg) + Lycopene (1.8 mg) + D-Alpha-Tocopherol (10 IU) For The Treatment Of Skin Aging
  Condition or outcome area: Skin Aging|Wrinkles
  2018-03-05 · Subject: Lycopene; all-trans-Lycopene; Lycopene all-trans-; C05432; Spectrum4_001998; KBio2_002146; Lycopene, all-trans- (8CI); BSPBio_003389; (6E,8E,10E,12E,14E,16E,18E,20E,22E,24E,26E)-2,6,10,14,19,23,27,31-octamethyldotriaconta-2,6,8,10,12,14,16,18,20,22,24,26,30-tridecaene; trans-Lycopene · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT03460860 Completed (results not assessed here)
  Astaxanthin (2 mg) + Lycopene (1.8 mg) + D-Alpha-Tocopherol (10 IU) For The Treatment Of Skin Aging
  Condition or outcome area: Skin Aging|Wrinkles
  2018-03-05 · Subject: Astaxanthin; 3,3'-dihydroxy-4,4'-diketo-beta,beta-carotene · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT02397811 Completed (results not assessed here)
  Astaxanthin Formulation Bioavailability
  Condition or outcome area: Bioavailability of Astaxanthin Formulations
  2015-06 · Subject: Astaxanthin; 3,3'-dihydroxy-4,4'-diketo-beta,beta-carotene · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT02343497 Completed (results not assessed here)
  Lipid-lowering Effects of an Astaxanthin Supplement in Volunteers With Mild Dyslipidaemia
  Condition or outcome area: Dyslipidemias
  2014-08 · Subject: Astaxanthin; 3,3'-dihydroxy-4,4'-diketo-beta,beta-carotene · open the ingredient record · ClinicalTrials.gov
• Systematic review registration CRD42023470793 Registered protocol, no results here: Review Ongoing
  Astaxanthin and Improvement of Dementia: A Systematic Review of Current Clinical Trials
  Condition or outcome area: Cognitive impairment, reported subjectively and/ or objectively according to valid instrument/ testing
  2023-10-19 · Subject: Astaxanthin; 472-61-7; Ovoester; Astaxanthine; 3,3'-Dihydroxy-beta,beta-carotene-4,4'-dione; all-trans-Astaxanthin; BioAstin; (3S,3'S)-Astaxanthin; AstaREAL; Natupink · open the ingredient record
• Systematic review registration CRD42023437319 Registered protocol, no results here: Review Ongoing
  Effect of astaxanthin supplementation on plasma metabolites, inflammation, oxidative stress, fat and carbohydrate oxidation, physical performance and lipid profile in male during Exercise : A Systematic Review and Meta-Analysis
  Condition or outcome area: Effect of astaxanthin supplementation on plasma metabolites, inflammation, oxidative stress, fat and carbohydrate oxidation, physical performance and lipid profile in male during Exercise
  2023-06-27 · Subject: Astaxanthin; 472-61-7; Ovoester; Astaxanthine; 3,3'-Dihydroxy-beta,beta-carotene-4,4'-dione; all-trans-Astaxanthin; BioAstin; (3S,3'S)-Astaxanthin; AstaREAL; Natupink · open the ingredient record
• Systematic review registration CRD42023411548 Registered protocol, no results here: Review Completed not published
  Effects of Astaxanthin on Pathology-Related Biomarkers in Middle-Aged and Elderly Adults: A Systematic Review and Meta-Analysis
  Condition or outcome area: The rise in global life expectancy in recent decades has led to an aging population with an increased prevalence of chronic diseases, cognitive impairment, and disability. Oxidative stress, which results from an imbalance between oxidants and antioxidants, can lead to macromolecular damage, disruption of redox signaling and cellular control, and markers commonly observed in various diseases such as metabolic syndrome, chronic fatigue syndrome, neurodegenerative disorders, cardiovascular diseases
  2023-06-16 · Subject: Astaxanthin; 472-61-7; Ovoester; Astaxanthine; 3,3'-Dihydroxy-beta,beta-carotene-4,4'-dione; all-trans-Astaxanthin; BioAstin; (3S,3'S)-Astaxanthin; AstaREAL; Natupink · open the ingredient record
• Systematic review registration CRD42023409269 Registered protocol, no results here: Review Ongoing
  The effect of Astaxanthin intake on cardio-metabolic risk factors, Inflammatory, and liver enzymes: a systematic review and meta-analysis
  Condition or outcome area: unhealthy adults with metabolic syndrome and related diseases
  2023-03-29 · Subject: Astaxanthin; 472-61-7; Ovoester; Astaxanthine; 3,3'-Dihydroxy-beta,beta-carotene-4,4'-dione; all-trans-Astaxanthin; BioAstin; (3S,3'S)-Astaxanthin; AstaREAL; Natupink · open the ingredient record
• Systematic review registration CRD42023428043 Registered protocol, no results here: Review Ongoing
  The effects of astaxanthin supplementation on liver enzymes levels: A systematic review and meta-analysis of randomized controlled trials
  Condition or outcome area: Astaxanthin belongs to a group of carotenoids that are oxidized (1-3). It is a natural compound found in various sources such as algae, fish and birds (1).
  2023-05-31 · Subject: Astaxanthin; 472-61-7; Ovoester; Astaxanthine; 3,3'-Dihydroxy-beta,beta-carotene-4,4'-dione; all-trans-Astaxanthin; BioAstin; (3S,3'S)-Astaxanthin; AstaREAL; Natupink · open the ingredient record
• Systematic review registration CRD42022356955 Registered protocol, no results here: Review Ongoing
  Efficacy of astaxanthin supplementary on subjective fatigue, exercise performance, and cognitive function: A meta-analysis of randomizedcontrolled trials
  Condition or outcome area: Astaxanthin, extracted from Haematococcus pluvialis (H. pluvialis), is a natural nutrient of β-carotenoid, which possesses abundant beneficial properties, such as antioxidant, anti-inflammatory, and lipid-lowering activities. Recent randomized studies have reported the effectiveness of astaxanthin on improvement of fatigue, enhancement of exercise, as well as cognitive fitness. Actually, there were interactions among subjective fatigue, physical performance, and cognitive fitness. The less subje
  2022-09-10 · Subject: Astaxanthin; 472-61-7; Ovoester; Astaxanthine; 3,3'-Dihydroxy-beta,beta-carotene-4,4'-dione; all-trans-Astaxanthin; BioAstin; (3S,3'S)-Astaxanthin; AstaREAL; Natupink · open the ingredient record
• Systematic review registration CRD42022335796 Registered protocol, no results here: Review Ongoing
  Efficacy of astaxanthin in animal models of type 2 diabetes mellitus: a systematic review and meta-analysis
  2022-06-07 · Subject: Astaxanthin; 472-61-7; Ovoester; Astaxanthine; 3,3'-Dihydroxy-beta,beta-carotene-4,4'-dione; all-trans-Astaxanthin; BioAstin; (3S,3'S)-Astaxanthin; AstaREAL; Natupink · open the ingredient record
• Systematic review registration CRD42021275708 Registered protocol, no results here: Review Ongoing
  Impact of Astaxanthin supplementation on blood pressure: A systematic review and meta-analysis of randomized controlled trials
  Condition or outcome area: Hypertension (HTN) is the common modifiable risk factor for cardiovascular disease, stroke, renal dysfunction, and mortality worldwide. Threshold values used to define hypertension have been recently reduced as Systolic blood pressure (SBP) ≥ 130 mmHg or diastolic blood pressure (DBP) ≥ 80 mmHg. In 2010, the global prevalence of HTN was 31.1%. It has an increasing rate due to the population aging and rising exposure to lifestyle risk factors, especially in low- and middle-income countries.
  2021-09-29 · Subject: Astaxanthin; 472-61-7; Ovoester; Astaxanthine; 3,3'-Dihydroxy-beta,beta-carotene-4,4'-dione; all-trans-Astaxanthin; BioAstin; (3S,3'S)-Astaxanthin; AstaREAL; Natupink · open the ingredient record
• Systematic review registration CRD42020215881 Registered protocol, no results here: Review Completed published
  A systematic review of astaxanthin on the risk factors of metabolic syndrome
  Condition or outcome area: Risk factors of metabolic syndrome, type 2 diabetes mellitus
  2020-12-20 · Subject: Astaxanthin; 472-61-7; Ovoester; Astaxanthine; 3,3'-Dihydroxy-beta,beta-carotene-4,4'-dione; all-trans-Astaxanthin; BioAstin; (3S,3'S)-Astaxanthin; AstaREAL; Natupink · open the ingredient record
• Publication PMID 36354983 Research model: Cell Experiment
  Astaxanthin Exerts Immunomodulatory Effect by Regulating SDH-HIF-1α Axis and Reprogramming Mitochondrial Metabolism in LPS-Stimulated RAW264.7 Cells
  Condition or outcome area: inflammatory diseases; mitochondrial dysfunction; metabolic disorders
  Mar Drugs · 2022 · Subject: Astaxanthin; 472-61-7; Ovoester; Astaxanthine; 3,3'-Dihydroxy-beta,beta-carotene-4,4'-dione; all-trans-Astaxanthin; BioAstin; (3S,3'S)-Astaxanthin; AstaREAL; Natupink · open the ingredient record · DOI 10.3390/md20110660
• Publication PMID 36008933 Research model: Animal & Cell Experiment
  Astaxanthin Carotenoid Modulates Oxidative Stress in Adipose-Derived Stromal Cells Isolated from Equine Metabolic Syndrome Affected Horses by Targeting Mitochondrial Biogenesis
  Condition or outcome area: metabolic syndrome; mitochondrial dysfunction
  Biomolecules · 2022 · Subject: Astaxanthin; 472-61-7; Ovoester; Astaxanthine; 3,3'-Dihydroxy-beta,beta-carotene-4,4'-dione; all-trans-Astaxanthin; BioAstin; (3S,3'S)-Astaxanthin; AstaREAL; Natupink · open the ingredient record · DOI 10.3390/biom12081039
• Publication PMID 35267937 Research model: Animal & Cell Experiment
  Astaxanthin Attenuates the Changes in the Expression of MicroRNAs Involved in the Activation of Hepatic Stellate Cells
  Condition or outcome area: liver fibrosis; aHSC
  Nutrients · 2022 · Subject: Astaxanthin; 472-61-7; Ovoester; Astaxanthine; 3,3'-Dihydroxy-beta,beta-carotene-4,4'-dione; all-trans-Astaxanthin; BioAstin; (3S,3'S)-Astaxanthin; AstaREAL; Natupink · open the ingredient record · DOI 10.3390/nu14050962
• Publication PMID 35204257 Research model: Cell Experiment
  Astaxanthin Sensitizes Low SOD2-Expressing GBM Cell Lines to TRAIL Treatment via Pathway Involving Mitochondrial Membrane Depolarization
  Condition or outcome area: cancer; tumor; glioblastoma multiforme
  Antioxidants (Basel) · 2022 · Subject: Astaxanthin; 472-61-7; Ovoester; Astaxanthine; 3,3'-Dihydroxy-beta,beta-carotene-4,4'-dione; all-trans-Astaxanthin; BioAstin; (3S,3'S)-Astaxanthin; AstaREAL; Natupink · open the ingredient record · DOI 10.3390/antiox11020375
• Publication PMID 35038495 Research model: Animal & Cell Experiment
  A smart cauliflower-like carrier for astaxanthin delivery to relieve colon inflammation
  Condition or outcome area: colitis; ulcerative colitis; tumor
  J Control Release · 2022 · Subject: Astaxanthin; 472-61-7; Ovoester; Astaxanthine; 3,3'-Dihydroxy-beta,beta-carotene-4,4'-dione; all-trans-Astaxanthin; BioAstin; (3S,3'S)-Astaxanthin; AstaREAL; Natupink · open the ingredient record · DOI 10.1016/j.jconrel.2022.01.014
• Publication PMID 34940651 Research model: Animal Experiment
  Inhibitory Effect of Astaxanthin on Testosterone-Induced Benign Prostatic Hyperplasia in Rats
  Condition or outcome area: benign prostatic hyperplasia
  Mar Drugs · 2021 · Subject: Astaxanthin; 472-61-7; Ovoester; Astaxanthine; 3,3'-Dihydroxy-beta,beta-carotene-4,4'-dione; all-trans-Astaxanthin; BioAstin; (3S,3'S)-Astaxanthin; AstaREAL; Natupink · open the ingredient record · DOI 10.3390/md19120652
• Publication PMID 34825683 Research model: Animal Experiment
  Astaxanthin alleviates inflammatory pain by regulating the p38 mitogen-activated protein kinase and nuclear factor-erythroid factor 2-related factor/heme oxygenase-1 pathways in mice
  Condition or outcome area: inflammation; Inflammatory pain; thermal hyperalgesia; inflammatory pain; Complete Freund's adjuvant
  Food Funct · 2021 · Subject: Astaxanthin; 472-61-7; Ovoester; Astaxanthine; 3,3'-Dihydroxy-beta,beta-carotene-4,4'-dione; all-trans-Astaxanthin; BioAstin; (3S,3'S)-Astaxanthin; AstaREAL; Natupink · open the ingredient record · DOI 10.1039/d1fo02326h
• Publication PMID 34684576 Research model: Animal Experiment
  Astaxanthin Inhibits Diabetes-Triggered Periodontal Destruction, Ameliorates Oxidative Complications in STZ-Injected Mice, and Recovers Nrf2-Dependent Antioxidant System
  Condition or outcome area: periodontal destruction; hyperglycemia-triggered periodontal destruction; type I diabetes; diabetic; type I diabetic; hyperglycemia; hyperglycemia-associated chronic complications; diabetes-associated periodontal destruction; diabetes; periodontitis
  Nutrients · 2021 · Subject: Astaxanthin; 472-61-7; Ovoester; Astaxanthine; 3,3'-Dihydroxy-beta,beta-carotene-4,4'-dione; all-trans-Astaxanthin; BioAstin; (3S,3'S)-Astaxanthin; AstaREAL; Natupink · open the ingredient record · DOI 10.3390/nu13103575
• Publication PMID 34681695 Research model: Animal Experiment
  Astaxanthin Prevents Diet-Induced NASH Progression by Shaping Intrahepatic Immunity
  Condition or outcome area: non-alcoholic steatohepatitis; liver fibrosis; non-alcoholic fatty liver disease; steatosis
  Int J Mol Sci · 2021 · Subject: Astaxanthin; 472-61-7; Ovoester; Astaxanthine; 3,3'-Dihydroxy-beta,beta-carotene-4,4'-dione; all-trans-Astaxanthin; BioAstin; (3S,3'S)-Astaxanthin; AstaREAL; Natupink · open the ingredient record · DOI 10.3390/ijms222011037
• Publication PMID 34677433 Research model: Animal Experiment
  Astaxanthin Provides Antioxidant Protection in LPS-Induced Dendritic Cells for Inflammatory Control
  Condition or outcome area: sepsis
  Mar Drugs · 2021 · Subject: Astaxanthin; 472-61-7; Ovoester; Astaxanthine; 3,3'-Dihydroxy-beta,beta-carotene-4,4'-dione; all-trans-Astaxanthin; BioAstin; (3S,3'S)-Astaxanthin; AstaREAL; Natupink · open the ingredient record · DOI 10.3390/md19100534
• Publication PMID 34651285 Research model: Animal Experiment
  Astaxanthin attenuates hepatic steatosis in high-fat diet-fed rats by suppressing microRNA-21 via transactivation of nuclear factor erythroid 2-related factor 2
  Condition or outcome area: hepatic steatosis
  J Physiol Biochem · 2021 · Subject: Astaxanthin; 472-61-7; Ovoester; Astaxanthine; 3,3'-Dihydroxy-beta,beta-carotene-4,4'-dione; all-trans-Astaxanthin; BioAstin; (3S,3'S)-Astaxanthin; AstaREAL; Natupink · open the ingredient record · DOI 10.1007/s13105-021-00850-9
• Publication PMID 34439521 Research model: Cell Experiment
  Astaxanthin Inhibits Autophagic Cell Death Induced by Bisphenol A in Human Dermal Fibroblasts
  Condition or outcome area: oxidative stress-related diseases
  Antioxidants (Basel) · 2021 · Subject: Astaxanthin; 472-61-7; Ovoester; Astaxanthine; 3,3'-Dihydroxy-beta,beta-carotene-4,4'-dione; all-trans-Astaxanthin; BioAstin; (3S,3'S)-Astaxanthin; AstaREAL; Natupink · open the ingredient record · DOI 10.3390/antiox10081273
• Publication PMID 34204220 Research model: Animal Experiment
  Astaxanthin Protects Dendritic Cells from Lipopolysaccharide-Induced Immune Dysfunction
  Condition or outcome area: sepsis
  Mar Drugs · 2021 · Subject: Astaxanthin; 472-61-7; Ovoester; Astaxanthine; 3,3'-Dihydroxy-beta,beta-carotene-4,4'-dione; all-trans-Astaxanthin; BioAstin; (3S,3'S)-Astaxanthin; AstaREAL; Natupink · open the ingredient record · DOI 10.3390/md19060346
• Publication PMID 33530505 Research model: Animal Experiment
  Astaxanthin Prevents Atrophy in Slow Muscle Fibers by Inhibiting Mitochondrial Reactive Oxygen Species via a Mitochondria-Mediated Apoptosis Pathway
  Condition or outcome area: muscle atrophy
  Nutrients · 2021 · Subject: Astaxanthin; 472-61-7; Ovoester; Astaxanthine; 3,3'-Dihydroxy-beta,beta-carotene-4,4'-dione; all-trans-Astaxanthin; BioAstin; (3S,3'S)-Astaxanthin; AstaREAL; Natupink · open the ingredient record · DOI 10.3390/nu13020379
• Publication PMID 33505592 Research model: Animal Experiment
  Astaxanthin Alleviates Ochratoxin A-Induced Cecum Injury and Inflammation in Mice by Regulating the Diversity of Cecal Microbiota and TLR4/MyD88/NF- κ B Signaling Pathway
  Oxid Med Cell Longev · 2021 · Subject: Astaxanthin; 472-61-7; Ovoester; Astaxanthine; 3,3'-Dihydroxy-beta,beta-carotene-4,4'-dione; all-trans-Astaxanthin; BioAstin; (3S,3'S)-Astaxanthin; AstaREAL; Natupink · open the ingredient record · DOI 10.1155/2021/8894491
• Publication PMID 33359248 Research model: Animal & Cell Experiment
  Astaxanthin inhibits microglia M1 activation against inflammatory injury triggered by lipopolysaccharide through down-regulating miR-31-5p
  Life Sci · 2021 · Subject: Astaxanthin; 472-61-7; Ovoester; Astaxanthine; 3,3'-Dihydroxy-beta,beta-carotene-4,4'-dione; all-trans-Astaxanthin; BioAstin; (3S,3'S)-Astaxanthin; AstaREAL; Natupink · open the ingredient record · DOI 10.1016/j.lfs.2020.118943
• Publication PMID 33326114 Research model: Animal Experiment
  Astaxanthin ameliorates oxidative stress and neuronal apoptosis via SIRT1/NRF2/Prx2/ASK1/p38 after traumatic brain injury in mice
  Condition or outcome area: Brain oedema; traumatic brain injury; brain injury
  Br J Pharmacol · 2021 · Subject: Astaxanthin; 472-61-7; Ovoester; Astaxanthine; 3,3'-Dihydroxy-beta,beta-carotene-4,4'-dione; all-trans-Astaxanthin; BioAstin; (3S,3'S)-Astaxanthin; AstaREAL; Natupink · open the ingredient record · DOI 10.1111/bph.15346
• Publication PMID 33269751 Research model: Animal Experiment
  Astaxanthin alleviates pathological brain aging through the upregulation of hippocampal synaptic proteins
  Neural Regen Res · 2021 · Subject: Astaxanthin; 472-61-7; Ovoester; Astaxanthine; 3,3'-Dihydroxy-beta,beta-carotene-4,4'-dione; all-trans-Astaxanthin; BioAstin; (3S,3'S)-Astaxanthin; AstaREAL; Natupink · open the ingredient record · DOI 10.4103/1673-5374.300460
• Publication PMID 33132140 Research model: Animal Experiment
  Astaxanthin improves serum cytokine expression and semen quality of diabetes mellitus KKAy mice
  Condition or outcome area: diabetes mellitus; infertility; KKAy
  Chem Biol Interact · 2020 · Subject: Astaxanthin; 472-61-7; Ovoester; Astaxanthine; 3,3'-Dihydroxy-beta,beta-carotene-4,4'-dione; all-trans-Astaxanthin; BioAstin; (3S,3'S)-Astaxanthin; AstaREAL; Natupink · open the ingredient record · DOI 10.1016/j.cbi.2020.109303
• Publication PMID 33047770 Research model: Animal Experiment
  Inflammation response after the cessation of chronic arsenic exposure and post-treatment of natural astaxanthin in liver: potential role of cytokine-mediated cell-cell interactions
  Condition or outcome area: liver injury
  Food Funct · 2020 · Subject: Astaxanthin; 472-61-7; Ovoester; Astaxanthine; 3,3'-Dihydroxy-beta,beta-carotene-4,4'-dione; all-trans-Astaxanthin; BioAstin; (3S,3'S)-Astaxanthin; AstaREAL; Natupink · open the ingredient record · DOI 10.1039/d0fo01223h
• Publication PMID 33008094 Research model: Cell Experiment
  Astaxanthin Suppresses PM2.5-Induced Neuroinflammation by Regulating Akt Phosphorylation in BV-2 Microglial Cells
  Condition or outcome area: neurological disorders; Parkinson's disease; dementia; Alzheimer's disease
  Int J Mol Sci · 2020 · Subject: Astaxanthin; 472-61-7; Ovoester; Astaxanthine; 3,3'-Dihydroxy-beta,beta-carotene-4,4'-dione; all-trans-Astaxanthin; BioAstin; (3S,3'S)-Astaxanthin; AstaREAL; Natupink · open the ingredient record · DOI 10.3390/ijms21197227
• Publication PMID 32998286 Research model: Cell Experiment
  Astaxanthin Inhibits p70 S6 Kinase 1 Activity to Sensitize Insulin Signaling
  Condition or outcome area: hyperglycemia; diabetic
  Mar Drugs · 2020 · Subject: Astaxanthin; 472-61-7; Ovoester; Astaxanthine; 3,3'-Dihydroxy-beta,beta-carotene-4,4'-dione; all-trans-Astaxanthin; BioAstin; (3S,3'S)-Astaxanthin; AstaREAL; Natupink · open the ingredient record · DOI 10.3390/md18100495
• Publication PMID 32937179 Research model: Animal Experiment
  Kidney-targeted astaxanthin natural antioxidant nanosystem for diabetic nephropathy therapy
  Condition or outcome area: diabetic nephropathy; diabetes mellitus; Diabetic nephropathy
  Eur J Pharm Biopharm · 2020 · Subject: Astaxanthin; 472-61-7; Ovoester; Astaxanthine; 3,3'-Dihydroxy-beta,beta-carotene-4,4'-dione; all-trans-Astaxanthin; BioAstin; (3S,3'S)-Astaxanthin; AstaREAL; Natupink · open the ingredient record · DOI 10.1016/j.ejpb.2020.09.005
• Publication PMID 32918989 Research model: Animal Experiment
  Protective effect of astaxanthin against SnS2 nanoflowers induced testes toxicity by suppressing RIPK1-RIPK3-MLKL signaling in mice
  Condition or outcome area: inflammation
  Food Chem Toxicol · 2020 · Subject: Astaxanthin; 472-61-7; Ovoester; Astaxanthine; 3,3'-Dihydroxy-beta,beta-carotene-4,4'-dione; all-trans-Astaxanthin; BioAstin; (3S,3'S)-Astaxanthin; AstaREAL; Natupink · open the ingredient record · DOI 10.1016/j.fct.2020.111736
• Publication PMID 32857080 Research model: Animal Experiment
  Astaxanthin attenuates oxidative stress and immune impairment in D-galactose-induced aging in rats by activating the Nrf2/Keap1 pathway and suppressing the NF-κB pathway
  Condition or outcome area: immune impairment
  Food Funct · 2020 · Subject: Astaxanthin; 472-61-7; Ovoester; Astaxanthine; 3,3'-Dihydroxy-beta,beta-carotene-4,4'-dione; all-trans-Astaxanthin; BioAstin; (3S,3'S)-Astaxanthin; AstaREAL; Natupink · open the ingredient record · DOI 10.1039/d0fo01663b
• Publication PMID 32801029 Research model: Animal & Cell Experiment
  Astaxanthin inhibits alcohol-induced inflammation and oxidative stress in macrophages in a sirtuin 1-dependent manner
  Condition or outcome area: tumor
  J Nutr Biochem · 2020 · Subject: Astaxanthin; 472-61-7; Ovoester; Astaxanthine; 3,3'-Dihydroxy-beta,beta-carotene-4,4'-dione; all-trans-Astaxanthin; BioAstin; (3S,3'S)-Astaxanthin; AstaREAL; Natupink · open the ingredient record · DOI 10.1016/j.jnutbio.2020.108477
• Publication PMID 32784629 Research model: Cell Experiment
  Anti-Tumor Effects of Astaxanthin by Inhibition of the Expression of STAT3 in Prostate Cancer
  Condition or outcome area: tumor; prostate cancer; PCa
  Mar Drugs · 2020 · Subject: Astaxanthin; 472-61-7; Ovoester; Astaxanthine; 3,3'-Dihydroxy-beta,beta-carotene-4,4'-dione; all-trans-Astaxanthin; BioAstin; (3S,3'S)-Astaxanthin; AstaREAL; Natupink · open the ingredient record · DOI 10.3390/md18080415
• Publication PMID 32722441 Research model: Cell Experiment
  Protective Effect of Astaxanthin on Blue Light Light-Emitting Diode-Induced Retinal Cell Damage via Free Radical Scavenging and Activation of PI3K/Akt/Nrf2 Pathway in 661W Cell Model
  Condition or outcome area: retinal injury
  Mar Drugs · 2020 · Subject: Astaxanthin; 472-61-7; Ovoester; Astaxanthine; 3,3'-Dihydroxy-beta,beta-carotene-4,4'-dione; all-trans-Astaxanthin; BioAstin; (3S,3'S)-Astaxanthin; AstaREAL; Natupink · open the ingredient record · DOI 10.3390/md18080387
• Publication PMID 32673631 Research model: Animal Experiment
  Protective effect of astaxanthin against La2O3 nanoparticles induced neurotoxicity by activating PI3K/AKT/Nrf-2 signaling in mice
  Condition or outcome area: hippocampal injury
  Food Chem Toxicol · 2020 · Subject: Astaxanthin; 472-61-7; Ovoester; Astaxanthine; 3,3'-Dihydroxy-beta,beta-carotene-4,4'-dione; all-trans-Astaxanthin; BioAstin; (3S,3'S)-Astaxanthin; AstaREAL; Natupink · open the ingredient record · DOI 10.1016/j.fct.2020.111582
• Publication PMID 32604880 Research model: Cell Experiment
  Astaxanthin Counteracts Excitotoxicity and Reduces the Ensuing Increases in Calcium Levels and Mitochondrial Reactive Oxygen Species Generation
  Condition or outcome area: neurodegenerative pathologies
  Mar Drugs · 2020 · Subject: Astaxanthin; 472-61-7; Ovoester; Astaxanthine; 3,3'-Dihydroxy-beta,beta-carotene-4,4'-dione; all-trans-Astaxanthin; BioAstin; (3S,3'S)-Astaxanthin; AstaREAL; Natupink · open the ingredient record · DOI 10.3390/md18060335